Mitchell Runge, PA
Medical · Creve Coeur, MONPI 1497231013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,759, more than ten times the $27 reported in 2022.
Across 127 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$291
- Novo Nordisk$271
- Lilly USA, LLC$224
- Axsome Therapeutics, Inc.$178
- Amgen$169
- AstraZeneca$161
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,311100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 19 | $291 |
| Novo Nordisk | 15 | $271 |
| Lilly USA, LLC | 11 | $224 |
| Axsome Therapeutics, Inc. | 13 | $178 |
| Amgen | 9 | $169 |
| AstraZeneca | 8 | $161 |
| GSK | 9 | $158 |
| AbbVie | 8 | $152 |
| Novartis | 5 | $95 |
| Eisai Inc. | 2 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Merck | 3 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Procept Biorobotics Corporation | 1 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $34 |
| Exact Sciences | 2 | $33 |
| Globus Medical | 1 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Edwards Lifesciences | 1 | $24 |
| Bayer | 1 | $22 |
| Medtronic | 1 | $21 |
| Abbott | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
How this compares
$2,311 in reported general payments places this provider in the 75th percentile of 198 medical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $654 |
| Doxycycline Hyclate | 30 | $278 |
| Methylprednisolone | 25 | $220 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $211 |
| Fluticasone Propionate | 27 | $174 |
| Triamcinolone Acetonide | 17 | $86 |
| Cyclobenzaprine Hcl | 11 | $68 |
| Ciprofloxacin Hcl | 11 | $67 |
| Prednisone | 40 | $66 |
| Azithromycin | 20 | $51 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $46 |
| Rosuvastatin Calcium | 13 | $43 |
| Meloxicam | 14 | $19 |
| Furosemide | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other medical in Creve Coeur
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
- Erin YoffieSaint Louis$16K
- Corey WhitesidesColumbia$15K
- David WinchellSaint Peters$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.